SOVUQ ZANJIR (COLD CHAIN) BUZILISHI VA VAKSINA SAMARADORLIGI.
Abstract
Vaksinalarning samaradorligi ularni ishlab chiqarishdan boshlab qo‘llashgacha bo‘lgan bosqichlarda sovuq zanjirga qat’iy rioya qilinishiga bog‘liq. Harorat rejimining buzilishi vaksinaning immunogenligini pasaytirishi, klinik samaradorligini kamaytirishi va noto‘g‘ri emlash natijalariga olib kelishi mumkin. Ushbu maqolada sovuq zanjir tushunchasi, buzilish sabablari, vaksinalarga ta’siri hamda nazorat mexanizmlari tahlil qilinadi.
References
1. World Health Organization. Temperature sensitivity of vaccines. Geneva: WHO; 2006.
2. World Health Organization. Immunization in practice: A practical guide for health staff. Geneva: WHO; 2015.
3. UNICEF. Effective Vaccine Management (EVM) Initiative. New York: UNICEF; 2019.
4. Gavi, the Vaccine Alliance. Cold chain equipment optimization platform (CCEOP). Geneva: Gavi; 2020.
5. Matthias DM, Robertson J, Garrison MM, Newland S, Nelson C. Freezing temperatures in the vaccine cold chain. Vaccine. 2007;25(20):3980–3986.
6. Kartoglu U, Milstien J. Tools and approaches to ensure quality of vaccines throughout the cold chain. Expert Review of Vaccines. 2014;13(7):843–854.
7. Chen D, Kristensen D. Opportunities and challenges of vaccine thermostability. Human Vaccines & Immunotherapeutics. 2009;5(3):210–215.
8. Hanson CM, George AM, Sawadogo A, Schreiber B. Is freezing in the vaccine cold chain an ongoing issue? Vaccine. 2017;35(17):2127–2133.
9. Zipursky S, Djingarey MH, Lodjo JC, Olodo L, Tiendrebeogo S, Ronveaux O. Benefits of using vaccine vial monitors. Vaccine. 2011;29(38):7126–7130.
10. Centers for Disease Control and Prevention. Vaccine storage and handling toolkit. Atlanta: CDC; 2023.
